NOBEL ILAC Sanayii ve Ticaret A.S
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From NOBEL ILAC Sanayii ve Ticaret A.S
Turkey: Produce Selected Drugs Locally Or Lose Reimbursement
Turkey’s public payer body has said it will halt reimbursement of 54 products from 2018 unless manufacturers, including several multinationals, agree to start local production within a year.
Turkey Jostles For Slice Of Biologics Manufacturing Pie
Many local pharma companies in Turkey have been launching capital investments in new production facilities for biologics and biosimilars in the hope of attracting new foreign partners and have already met with some success, but a number of obstacles remain.
Turkey Launches Major New Biologics Projects
The Scientific and Technological Research Council of Turkey (TUBITAK) has kicked off two major new projects for biologics, one to develop and produce a biosimilar cancer drug and the other for a pandemic influenza vaccine.
Turkey Company Roundup: Biosimilar Pact, Keytruda Supply, Takeda Deal
TUBITAK (The Scientific and Technological Research Council of Turkey
) will produce biosimilars with Nobel Ilac, MSD provides pembrolizumab free to 25 patients in Turkey, Abdi Ibrahim intensifies its R&D efforts, and Takeda purchases a portfolio of new products.
Company Information
- Industry
- Pharmaceuticals
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice